AI In Medical Diagnostics Global Market Opportunities And Strategies To 2034
상품코드:1729077
리서치사:The Business Research Company
발행일:2025년 05월
페이지 정보:영문 314 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 의료진단용 AI 시장 규모는 2019년 4억 5,183만 달러로 평가되었으며, 2024년까지 연평균 복합 성장률(CAGR) 33.00% 이상으로 성장했습니다.
맞춤형 의료에 대한 수요 증가
맞춤형 의료에 대한 수요 증가는 의료 진단에서 AI 시장의 성장을 가속했습니다. 2023년 2월, 과학자, 환자, 의료 제공자를 대표해 환자와 의료 제도에 이익을 가져오는 맞춤형 의료의 이해와 도입을 추진하는 미국을 거점으로 하는 조직, 맞춤형 의료 연합(PMC)에 따르면, 2022년에는 미국 식품의약국에서 신약 승인의 34%를 개별화 의약품이 차지했고 지난 8년간 모두 승인의 25% 이상을 개별화 의약품이 차지했으며, 2022년에는 12개의 새로운 개별화 의약품이 승인되어 이전에 비해 크게 증가했습니다.
본 보고서는 세계의 의료진단용 AI시장에 대해 조사했으며, 시장 개요와 함께 컴포넌트별, 용도별, 최종 사용자별, 기술별, 전문분야별, 지역 및 국가별 동향 및 시장 진출기업 프로파일 등의 정보를 제공합니다.
목차
제1장 주요 요약
제2장 목차
제3장 테이블 목록
제4장 도표 일람
제5장 보고서 구성
제6장 시장 특징
일반 시장 정의
요약
의료진단용 AI 시장의 정의와 세분화
컴포넌트별 시장 세분화
소프트웨어
하드웨어
서비스
용도별 시장 세분화
컴퓨터 지원 검출
컴퓨터 지원 진단
정량 분석 툴
임상적 판단
최종 사용자별 시장 세분화
병원
진단 이미지 센터
진단실험실
기타
기술별 시장 세분화
자연언어처리
컴퓨터 비전
머신러닝
컨텍스트 인식 컴퓨팅
전문 분야별 시장 세분화
심장병학
종양학
병리학
방사선과
흉부와 폐
신경학
기타
제7장 주요 시장 동향
AI를 활용하여 의료 업무를 효율화하고, 헬스케어 시스템 전체에서 케어의 과정을 최적화
AI를 활용한 방사선 솔루션으로 헬스케어 효율을 변화시켜 보다 빠르고 정확한 결과를 실현
AI를 활용한 헬스케어 워크플로우의 혁신으로 의사의 불타는 증후군을 해소해, 생산성을 향상
광전식 용적맥파 기록법이나 기타 센서 기술을 활용한 바이탈 사인 모니터링의 진보
AI 기반 바이오마커 식별별 개별화 암 치료 강화
정확하고 임상적으로 신뢰할 수 있는 정보를 감지하기 위한 고급 진단 도구 출시
간 질환 진단을 위한 의료 영상에서 정량적 보고서의 통합
개인화된 AI 인사이트 별 의사 결정의 변화를 향한 투자 증가
주요 시장 진출기업 간의 전략적 파트너십 및 협업
제8장 의료진단용 AI 시장 - 거시경제 시나리오
제9장 세계 시장 규모와 성장
시장 규모
시장 성장 실적, 2019년-2024년
시장 성장 예측, 2024년-2029년, 2034년
제10장 세계의 의료진단용 AI 시장 세분화
세계의 의료진단용 AI 시장 : 컴포넌트별
세계의 의료진단용 AI 시장 : 용도별
세계의 의료진단용 AI 시장 : 최종사용자별
세계의 의료진단용 AI 시장 : 기술별
세계의 의료진단용 AI 시장 : 전문 분야별
제11장 의료진단시장에서의 AI, 지역별·국가별 분석
세계의 의료진단용 AI 시장 :지역별, 과거 분석과 예측, 2019년-2024년, 2029년 예측, 2034년 예측
세계의 의료진단용 AI 시장 : 국가별, 분석 및 예측(2019년-2024년, 2029년 예측, 2034년 예측)
제12장 아시아태평양 시장
제13장 서유럽 시장
제14장 동유럽 시장
제15장 북미 시장
제16장 남미 시장
제17장 중동 시장
제18장 아프리카 시장
제19장 경쟁 구도와 기업 프로파일
기업 프로파일
Siemens Healthineers AG
Merative LP
Tempus Labs
Enlitic Inc
GE HealthCare Technologies Inc
제20장 기타 대기업과 혁신기업
Microsoft Corporation
Koninklijke Philips NV
NVIDIA Corporation
PathAI Inc.
Aidoc Medical Ltd.
Ping An Healthcare and Technology Company Limited
HeartFlow Inc.
Qure.AI
Intel Corporation
Eko Health Inc.
Digital Diagnostics Inc.
Butterfly Network Inc.
AliveCor Inc.
Komodo Health Inc.
Behold.ai Technologies Ltd.
제21장 경쟁 벤치마킹
제22장 경쟁 대시보드
제23장 주요 인수합병(M&A)
Carta Healthcare, Realyze Intelligence 인수
DeepHealth, Keiron Medical Technologies Limited 인수
GE HealthCare, The Clinical AI Business From Intelligent Ultrasound 인수
Stryker Corporation이 Care.ai 인수
Quest Diagnostics, PathAI Diagnostics 인수
Lunit, Volpara 인수
Samsung Medison이 Sonio 인수
GE HealthCare Technologies, MIM Software 인수
Lunit, Volpara Health Technologies 인수
WELL Health Technologies, HEALWELL AI 인수
Philips가 DiA Imaging Analysis 인수
GE HealthCare, Caption Health 인수
BioNTech, InstaDeep 인수
Olympus Corporation이 Odin Vision 인수
Exo가 Medo AI 인수
RadNet이 Aidence 인수
제24장 기회와 전략
제25장 의료진단용 AI 시장의 결론 및 제안
제26장 부록
JHS
영문 목차
영문목차
Artificial Intelligence (AI) in medical diagnostics refers to the application of advanced computational algorithms and machine learning techniques to assist in the identification, analysis and interpretation of medical data for diagnosing diseases and conditions.
The AI in medical diagnostics market consists of sales of AI in medical diagnostics products and related services by entities (organizations, sole proprietors and partnerships) that use AI technologies to assist the analysis and interpretation of medical data for diagnostic purposes. AI in medical diagnostics leverages machine learning algorithms, natural language processing, computer vision and other advanced computational techniques to enhance the accuracy and efficiency of diagnosing diseases and medical conditions. This technology is utilized by healthcare professionals, including radiologists, pathologists and clinicians, to support clinical decision-making and improve patient outcomes.
The global AI in medical diagnostics market was valued at $451.83 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 33.00%.
Increase In Demand For Personalized Medicine
An increase in demand for personalized medicine propelled the growth of AI in medical diagnostics market. Personalized medicine, or precision medicine is an approach to medical care that aims to tailor treatments and interventions to the specific characteristics of each patient. AI-driven diagnostic tools excel in precise, personalized disease detection by analyzing complex data sets, including genetic, molecular and clinical information. This enhances accuracy and improves therapeutic outcomes in personalized medicine. In February 2023, the Personalized Medicine Coalition, a US-based organization that represents scientists, patients and providers, promoting the understanding and adoption of personalized medicine to benefit patients and the healthcare system, in 2022, according to the Personalized Medicine Coalition (PMC), a US-based company that advocates for personalized medicine, personalized medicines will account for 34% of new drug approvals by the US Food and Drug Administration in 2022 and have accounted for at least 25% of approvals in each of the previous eight years. Moreover, in 2022, approving 12 new personalized medicines accounted, marking a significant increase compared to previous years. Therefore, the increase in demand for personalized medicine supported the growth of the AI in medical diagnostics market during the historic period.
Utilizing AI To Streamline Medical Operations And Optimize Care Journeys Across the Healthcare System
Leading companies in the AI medical diagnostic market are optimizing operations and elevate patient care by improving diagnostic precision and automating routine tasks, AI tools enhance real-time decision-making and treatment effectiveness. These advancements reduce inefficiencies, minimize errors and promote more streamlined healthcare delivery, ultimately enhancing patient outcomes and maximizing resource utilization across the system. For example, in November 2024, GE HealthCare, a US-based medical technology company, launched an AI Innovation Lab to advance early-stage AI solutions as part of its broader digital strategy. The focus includes integrating AI into medical devices, enhancing decision-making across care journeys and improving outcomes and operational efficiency. Supported by cloud technology investments, the lab aims to scale AI development and deliver system-wide benefits.
The global AI in medical diagnostics market is highly concentrated, with large players operating in the market. The top ten competitors in the market made up to 60.90% of the total market in 2023.
AI In Medical Diagnostics Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global AI in medical diagnostics market as it emerges from the COVID-19 shut down.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for AI in medical diagnostics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The AI in medical diagnostics market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider AI in medical diagnostics market; and compares it with other markets.
The report covers the following chapters
Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by component, by application, by end user, by technology and by specialty.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the AI in medical diagnostics market.
Global Market Size And Growth- Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by component, by application, by end user, by technology and by specialty in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
Regional Market Size and Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for AI in medical diagnostics providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
